Bibliografia UJ CM

1/2
Lihi Eder, Satish Odhav, Mariusz Korkosz, Aubrey Trevelin Sprabery, Amanda M. Gellett, Chen-Yen Lin, So Young Park, Clinton C. Bertram, Alexis Ogdie.
Ixekizumab improves the signs and symptoms of psoriatic arthritis regardless of sex, duration of disease, or body mass index in two randomized, PHASE 3 clinical trials.
Annals of the Rheumatic Diseases
2019 : Vol. 78, suppl. 2, s. 904-905, abstr. FRI0430.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, June 12-15, 2019.
p-ISSN: 0003-4967
SZZ
SIF
Adres url:
2/2
Philip J. Mease, Desiree van der Heijde, Christopher T. Ritchlin, Masato Okada, Raquel S. Cuchacovich, Catherine L. Shuler, Chen-Yen Lin, Daniel K. Braun, Chin H. Lee, Dafna Gladman, SPIRIT-P1 Study Group.
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Annals of the Rheumatic Diseases
2017 : Vol. 76, nr 1, s. 79-87, il., bibliogr. 34 poz., abstr.
Autor korespondencyjny: Philip J. Mease.
Open Access Creative Commons Attribution License CC-BY-NC 4.0.
Data udostępnienia w sposób otwarty: 2016-08-23
p-ISSN: 0003-4967
AZ
ORG
AIF
IF: 12.350
Adres url:
Streszczenie w PubMed:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ